Policy & Regulations

This channel includes news coverage of healthcare policy and regulations set by Congress, the states, Centers for Disease Control and Prevention (CDC), the Department of Health and Human Services (HHS), U.S. Food and Drug Administration (FDA), and medical associations and societies. 

RSS icon
Thumbnail

FDA approval of several impactful drugs could be delayed if US defaults on debt

The FDA’s process of reviewing and approving drugs and devices could be put on hold, if lawmakers fail to reach a deal related to the debt ceiling.

biden administration artificial intelligence

White House spotlights 3 newly added items on AI to-do list

The Biden Administration has refreshed its efforts to encourage AI innovation while mitigating AI risks.

Federal Trade Commission issues warning to health companies about the misuse of consumer data

The new policy statement warns that any inaccurate or misleading claims to consumers about how their data is collected and used will be considered a violation of the FTC Act.

money maze payment reimbursement

'Forced to jump through hoops': Commercial insurers are making life harder for physicians

Although commercial payors do offer better reimbursement rates, their lack of timeliness in making payments is negatively impacting hospitals.

doctor telehealth computer screen

The best and worst states to practice medicine

Malpractice premiums appear to play a significant role in the rankings. Even states with ample job opportunities and low-to-moderate cost of living were ranked poorly due to their high malpractice premiums.

artificial intelligence federal regulation

Heard on Capitol Hill: ‘I can’t recall when we’ve had people come before us and plead with us to regulate them’

Washington has been all over AI this week. One highlight: OpenAI CEO Sam Altman testifying strongly in favor of federal AI oversight.

Thumbnail

How age, gender and medical specialty affect a physician's risk of being sued

New data from the American Medical Association reveal that nearly one-third of physicians in the United States have been sued during their medical career. 

framework for regulating healthcare artificial intelligence

A framework for regulating healthcare AI at the federal level has begun taking shape

America’s two major political parties agree on very little of late, but they have a mutual interest in working together toward overseeing AI.

Displaying 361 - 368 of 2769

Around the web

Cardiovascular Business
Q&A: Why are cardiovascular devices involved in so many recalls? FDA policies may be to blame

Cardiovascular devices are more likely to be in a Class I recall than any other device type. The FDA's approval process appears to be at least partially responsible, though the agency is working to make some serious changes. We spoke to a researcher who has been tracking these data for years to learn more. 

Cardiovascular Business
Cardiologist compensation still rising, especially in invasive and interventional cardiology

Updated compensation data includes good news for multiple subspecialties. The new report also examines private equity's impact on employment models and how much male cardiologists earn compared to females.

Cardiovascular Business
FDA’s tirzepatide decision creates uncertainty for patients—and leads to a lawsuit

When drugs are on the FDA’s shortage list, outsourcing facilities can produce their own compounded versions. When the FDA removed tirzepatide from that list with no warning, it created a considerable amount of chaos both behind the scenes and in pharmacies all over the country. 

Design by Adaptive Theme
Trimed Popup
Trimed Popup